Editors' ChoiceCancer

Antiangiogenic cancer drug drives lymphangiogenic metastasis

+ See all authors and affiliations

Science Translational Medicine  08 Feb 2017:
Vol. 9, Issue 376, eaam6060
DOI: 10.1126/scitranslmed.aam6060

You are currently viewing the abstract.

View Full Text

Abstract

Tumor blood vessel–destroying cancer drug induces development of tumor lymphatics that contribute to treatment failure.

View Full Text

Related Content